J
Jean-Jacques Body
Researcher at Université libre de Bruxelles
Publications - 397
Citations - 21506
Jean-Jacques Body is an academic researcher from Université libre de Bruxelles. The author has contributed to research in topics: Breast cancer & Zoledronic acid. The author has an hindex of 70, co-authored 384 publications receiving 19608 citations. Previous affiliations of Jean-Jacques Body include The Breast Cancer Research Foundation & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Decreased efficacy of bisphosphonates for recurrences of tumor-induced hypercalcemia.
TL;DR: In conclusion, pamidronate was progressively less efficient when hypercalcemia recurred, observed mainly in patients with hyperCalcemia of humoral origin.
Journal ArticleDOI
Bisphosphonates in the Treatment of Metastatic Breast Cancer
TL;DR: Longer administration of bisphosphonates reduces the frequency of morbid skeletal events by 30–40% in breast cancer metastatic to bone and in up to 50% in patients with multiple myeloma.
Journal ArticleDOI
Contribution of thyroid ultrasound and serum calcitonin to the diagnosis of congenital hypothyroidism
Jean-Pierre Chanoine,V. Toppet,Jean-Jacques Body,G. Van Vliet,Raphaël Lagasse,Pierre Bourdoux,M. Spehl,François Delange +7 more
TL;DR: TU and TS provide complementary information in the diagnosis of CH, and TU should be routinely performed in all newborns suspected of CH to avoid unnecessary use of TS in unaffected infants.
Journal ArticleDOI
Review of ibandronate in the treatment of metastatic bone disease: Experience from phase III trials
TL;DR: IV and oral ibandronate provide meaningful clinical benefits in patients with bone metastases from breast cancer, and both formulations reduce the risk of skeletal events and provide sustained relief from metastatic bone pain.
Journal ArticleDOI
Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference
Allan Lipton,James R. Berenson,Jean-Jacques Body,Brendan F. Boyce,Øyvind S. Bruland,Michael A. Carducci,Charles S. Cleeland,Denis R. Clohisy,Robert E. Coleman,Richard J. Cook,Theresa A. Guise,Roger N. Pearse,Trevor J. Powles,Michael J. Rogers,G. David Roodman,Matthew R. Smith,Larry J. Suva,Robert L. Vessella,Katherine N. Weilbaecher,Laura King +19 more
TL;DR: The First Cambridge Conference on Advances in Treating Metastatic Bone Cancer, a symposium held in Cambridge, Massachusetts, October 28 to 29, 2005, was convened to discuss recent advances and research related to the natural history of bone metastases and skeletal complications, bone cancer biology, treatment of myeloma and other solid tumors, and treatment-induced bone loss.